Yüklüyor......
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Polymyxin combination therapy is increasingly used clinically. However, systematic investigations of such combinations are a relatively recent phenomenon. The emerging pharmacodynamic (PD) and pharmacokinetic (PK) data on CMS/colistin and polymyxin B suggest that caution is required with monotherapy...
Kaydedildi:
| Yayımlandı: | Infect Dis Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4675771/ https://ncbi.nlm.nih.gov/pubmed/26645096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-015-0093-7 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|